We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Study Highlights Ethnic Diversity of Lupus-Linked Genes

By LabMedica International staff writers
Posted on 03 Aug 2017
A large genotyping study has identified multiple regions of the genome linked to the autoimmune disease systemic lupus erythematosus (SLE) in individuals of European, African, and Hispanic Amerindian ancestry.

SLE is an autoimmune disease with marked gender and ethnic disparities. More...
For example SLE strikes women nine times more frequently than men and its onset is most common during the childbearing years. Furthermore, African-American and Hispanic women are two to three times more likely to develop lupus and tend to have more severe cases than Caucasian women.

A recent study conducted by investigators at Wake Forest Baptist Medical Center (Winston-Salem, NC, USA) and colleagues in Oklahoma, the United Kingdom, and at the biotechnology company Genentech Inc. (San Francisco, CA, USA) analyzed genetic data from 27,574 individuals of European, African American, and Hispanic ancestry using Immunochip genotyping technology that had been designed specifically for autoimmune diseases.

The investigators reported that they had identified 58 regions of the genome linked to SLE in Caucasians, nine in African Americans, and 16 in Hispanics. These regions appeared to be independent of association with HLA (Human Leukocyte Antigen), and nearly 50% of these regions had multiple genetic variants that predisposed to SLE.

"This study is the largest multi-ethnic lupus genetics study to date and allowed us to identify many new genetic markers, some of which are specific to individual ethnic groups and others that are shared across ethnicities," said first author Dr. Carl Langefeld, professor of biostatistical sciences at Wake Forest Baptist Medical Center. "With this information, we can begin to better understand the differences in the rates and severity of disease across ethnic groups. In addition, we observed that many of the genetic markers associated with lupus are shared across numerous autoimmune diseases, and those that are not shared may allow us to understand why a person develops lupus instead of another autoimmune disease. These results will help us identify the biological pathways that pharmaceutical companies may target, and ultimately, develop personalized medicine for the treatment of lupus."

The study was published in the July 17, 2017, online edition of the journal Nature Communications.

Related Links:
Wake Forest Baptist Medical Center
Genentech



New
Gold Member
Automatic CLIA Analyzer
Shine i9000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.